Directory Image
This website uses cookies to improve user experience. By using our website you consent to all cookies in accordance with our Privacy Policy.

Generic Sorafenib Nexavar 200 Mg Cost/Price In USA, UK, Philippines, and India

Author: Jane Warner
by Jane Warner
Posted: Jan 10, 2019
side effects

Sorafenib(Nexavar) is used for the treatment of thyroid cancer, liver cancer and advanced kidney carcinoma (a type of kidney cancer). It works by inhibiting the growth and spread of the cancer cells.

Sorafenib is a part of a class of medicines – kinase inhibitors. Sorafenib stops the functions of an abnormal protein which signals a cancer cell to multiply and thereby stops the spread of the cancer. Sorafenib 200mg tablet are generally taken twice a day by consuming it orally. If you ever miss a dose, take it as soon as you remember. However, if the next dose is less than 12 hours away, you can skip the first one and avoid a double dose.

How to consume Sorafenat 200mg tablets (Sorafenib)?

Sorafenib is available in a tablet form. This tablet should be taken with sufficient water and it is generally taken twice a day. This medicine should be taken 2 hours before or after a meal. Do not stop taking the medicine without consulting with your doctor first.

Sorafenib can cause certain side effects like blood in urine, blurred vision, drowsiness, nausea, yellow eyes or skin, uterine bleeding and/or stomach irritation.

The lack of alertness is the main cause behind several cancer cases being untreated. People when starts experiencing a mild or major illness, simply call their physicians to seek quick solutions after which they forget about it. If you find certain signs such as weight loss, lower back pain, fatigue or fewer for several consecutive days, it is recommended to call an oncologist or a specialist doctor. All the mentioned symptoms are possible indication of the likelihood of being diagnosed with kidney cancer.

Oncologists generally use varying methods for the treatment of this cancer. However, around the world most oncologists suggest generic anti-cancer medicine – Generic Sorafenib Nexavar. This medicine is not recommended for people who are previously affected with cancer of lungs, allergies or high blood pressure. If you experience any of these indications, consult an oncologist prior to using the medication.

During the treatment with this medication, you may experience certain side effects like urinary blackness, vomiting, tinnitus, hemoptysis, hematuria, stomach pain, slow or rapid heartbeat, yellowing eyes or hematemesis. In such a case call your oncologist or nearby physician, as soon as possible.

How does Sorafenib functions?

This drug inhibits a signal within a cancer cell that makes them divide and breed. Barring this signal causes the cell to perish. Sorafenib also performs the same function with expansion of new blood vessels by cancer cells. This lowers the source of oxygen and other nutrients that results in the tumor to stop breeding and starts weakening.

Side effects

It is not necessary for the patient to experience all of the side effects. Such side effects also stop once the treatment is complete.

Some of the common side effects (that usually develops in almost 33% of patients)

  • Rashes
  • Low levels of phosphorus in blood
  • High volume of pancreatic enzymes in blood
  • Tiredness
  • Red, peeling and painful skin on the palms of the hand and the sole of the feet.
  • Diarrhea

Some of the less common side effects:

  • Loss in body Weight
  • Stomach cramps
  • Loss of appetite
  • Hair thinning or hair loss
  • Blood pressure getting higher

Immediately contact your doctor if you have severe spasm in stomach or diarrhea (4-6 times within a day)

About the Author

Author is actively involved in oncology drugs through their website cancercurepharmacy.com and updated about latest procedures for curing of Cancer or tumor through scientifically researched oncology drugs.

Rate this Article
Leave a Comment
Author Thumbnail
I Agree:
Comment 
Pictures
Author: Jane Warner

Jane Warner

Member since: Dec 19, 2018
Published articles: 3

Related Articles